220 related articles for article (PubMed ID: 16987901)
21. Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis.
Dick AD; Duncan L; Hale G; Waldmann H; Isaacs J
J Autoimmun; 1998 Jun; 11(3):255-64. PubMed ID: 9693974
[TBL] [Abstract][Full Text] [Related]
22. Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats.
Kurose S; Ikeda E; Tokiwa M; Hikita N; Mochizuki M
Exp Eye Res; 2000 Jan; 70(1):7-15. PubMed ID: 10644416
[TBL] [Abstract][Full Text] [Related]
23. Effects of experimental ocular inflammation on ocular immune privilege.
Ohta K; Wiggert B; Taylor AW; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
[TBL] [Abstract][Full Text] [Related]
24. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.
Sartani G; Silver PB; Rizzo LV; Chan CC; Wiggert B; Mastorakos G; Caspi RR
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2211-8. PubMed ID: 8843907
[TBL] [Abstract][Full Text] [Related]
25. Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate.
Sakai T; Kohno H; Ishihara T; Higaki M; Saito S; Matsushima M; Mizushima Y; Kitahara K
Exp Eye Res; 2006 Apr; 82(4):657-63. PubMed ID: 16360654
[TBL] [Abstract][Full Text] [Related]
26. Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis.
Fang IM; Yang CH; Lin CP; Yang CM; Chen MS
Exp Eye Res; 2004 Jun; 78(6):1043-55. PubMed ID: 15109911
[TBL] [Abstract][Full Text] [Related]
27. The effects of intraocular injection of interleukin-13 on endotoxin-induced uveitis in rats.
Lemaitre C; Thillaye-Goldenberg B; Naud MC; de Kozak Y
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2022-30. PubMed ID: 11481267
[TBL] [Abstract][Full Text] [Related]
28. Effects of the NF-kappaB inhibitor pyrrolidine dithiocarbamate on experimentally induced autoimmune anterior uveitis.
Yang CH; Fang IM; Lin CP; Yang CM; Chen MS
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1339-47. PubMed ID: 15790900
[TBL] [Abstract][Full Text] [Related]
29. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.
Crane IJ; McKillop-Smith S; Wallace CA; Lamont GR; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1547-52. PubMed ID: 11381059
[TBL] [Abstract][Full Text] [Related]
30. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
[TBL] [Abstract][Full Text] [Related]
31. Effects of systemic and intravitreal TNF-α inhibition in experimental autoimmune uveoretinitis.
Busch M; Bauer D; Hennig M; Wasmuth S; Thanos S; Heiligenhaus A
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):39-46. PubMed ID: 23211816
[TBL] [Abstract][Full Text] [Related]
32. Treatment of experimental autoimmune uveoretinitis with intravitreal injection of infliximab encapsulated in liposomes.
Zhang R; Qian J; Li X; Yuan Y
Br J Ophthalmol; 2017 Dec; 101(12):1731-1738. PubMed ID: 28986343
[TBL] [Abstract][Full Text] [Related]
33. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S
Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism.
Hoey S; Grabowski PS; Ralston SH; Forrester JV; Liversidge J
J Immunol; 1997 Nov; 159(10):5132-42. PubMed ID: 9366443
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina.
Dick AD; McMenamin PG; Körner H; Scallon BJ; Ghrayeb J; Forrester JV; Sedgwick JD
Eur J Immunol; 1996 May; 26(5):1018-25. PubMed ID: 8647162
[TBL] [Abstract][Full Text] [Related]
36. Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis.
Martin DF; DeBarge LR; Nussenblatt RB; Chan CC; Roberge FG
J Immunol; 1995 Jan; 154(2):922-7. PubMed ID: 7814893
[TBL] [Abstract][Full Text] [Related]
37. Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice.
Keino H; Takeuchi M; Kezuka T; Yamakawa N; Tsukahara R; Usui M
Graefes Arch Clin Exp Ophthalmol; 2003 Feb; 241(2):111-5. PubMed ID: 12605265
[TBL] [Abstract][Full Text] [Related]
38. Immunosuppressive effects of polynactins (tetranactin, trinactin and dinactin) on experimental autoimmune uveoretinitis in rats.
Tanouchi Y; Shichi H
Jpn J Ophthalmol; 1987; 31(2):218-29. PubMed ID: 3499534
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of endotoxin-induced uveitis and potentiation of local TNF-alpha and interleukin-6 mRNA expression by interleukin-13.
Marie O; Thillaye-Goldenberg B; Naud MC; de Kozak Y
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2275-82. PubMed ID: 10476793
[TBL] [Abstract][Full Text] [Related]
40. Effects of cyclosporine and other immunosuppressive drugs on experimental autoimmune uveoretinitis in rats.
Mochizuki M; Nussenblatt RB; Kuwabara T; Gery I
Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):226-32. PubMed ID: 3871750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
